{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:43:43Z","timestamp":1793835823911,"version":"4.6.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04643-5","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T07:57:05Z","timestamp":1759219025000},"page":"3477-3494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Distribution of acquired carbapenemase genes among uropathogenic Escherichia coli"],"prefix":"10.1007","volume":"399","author":[{"given":"Shervindokht","family":"Ahmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Foroohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Shirzadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas Fallah","family":"Vosoughi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Golpasand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Behzadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"4643_CR1","doi-asserted-by":"publisher","unstructured":"Algammal AM, B.P. Antimicrobial resistance: a global public health concern that needs perspective combating strategies and new talented antibiotics. Discov Med. 2024, 36:1911\u20131913, https:\/\/doi.org\/10.24976\/Discov.Med.202436188.177.","DOI":"10.24976\/Discov.Med.202436188.177"},{"key":"4643_CR2","doi-asserted-by":"publisher","first-page":"1135614","DOI":"10.3389\/fmicb.2023.1135614","volume":"14","author":"A Algammal","year":"2023","unstructured":"Algammal A, Hetta HF, Mabrok M, Behzadi P (2023) Emerging multidrug-resistant bacterial pathogens \u201csuperbugs\u201d: a rising public health threat. Front Microbiol 14:1135614","journal-title":"Front Microbiol"},{"key":"4643_CR3","first-page":"31","volume":"12","author":"H Alizadeh","year":"2024","unstructured":"Alizadeh H, Khodavandi A, Alizadeh F, Bahador N (2024) Phenotypic and genotypic identification of metallobetalactamase genes in resistant Enterobacteriaceae isolated from medical centers in Isfahan. Novelty in Biomedicine 12:31\u201342","journal-title":"Novelty in Biomedicine"},{"key":"4643_CR4","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41585-021-00477-x","volume":"18","author":"I Ambite","year":"2021","unstructured":"Ambite I, Butler D, Wan MLY, Rosenblad T, Tran TH, Chao SM, Svanborg C (2021) Molecular determinants of disease severity in urinary tract infection. Nat Rev Urol 18:468\u2013486","journal-title":"Nat Rev Urol"},{"key":"4643_CR5","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001462","volume":"70","author":"T Armstrong","year":"2021","unstructured":"Armstrong T, Fenn SJ, Hardie KR (2021) JMM profile: carbapenems: a broad-spectrum antibiotic. J Med Microbiol 70:001462","journal-title":"J Med Microbiol"},{"key":"4643_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3390\/antibiotics11030421","volume":"11","author":"C Aurilio","year":"2022","unstructured":"Aurilio C, Sansone P, Barbarisi M, Pota V, Giaccari LG, Coppolino F, Barbarisi A, Passavanti MB, Pace MC (2022) Mechanisms of action of carbapenem resistance. Antibiotics 11:421","journal-title":"Antibiotics"},{"key":"4643_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00937-17","author":"A Bauwens","year":"2017","unstructured":"Bauwens A, Kunsmann L, Karch H, Mellmann A, Bielaszewska M (2017) Antibiotic-mediated modulations of outer membrane vesicles in enterohemorrhagic Escherichia coli O104: H4 and O157: H7. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00937-17","journal-title":"Antimicrob Agents Chemother"},{"key":"4643_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12223-019-00719-x","volume":"65","author":"P Behzadi","year":"2020","unstructured":"Behzadi P (2020) Classical chaperone-usher (CU) adhesive fimbriome: uropathogenic Escherichia coli (UPEC) and urinary tract infections (UTIs). Folia Microbiol 65:45\u201365","journal-title":"Folia Microbiol"},{"key":"4643_CR9","doi-asserted-by":"crossref","unstructured":"Behzadi P (2021) The role of Toll-like receptor (TLR) polymorphisms in urinary bladder cancer. Genetic Polymorphism and cancer susceptibility pp. 281\u2013317.","DOI":"10.1007\/978-981-33-6699-2_9"},{"key":"4643_CR10","first-page":"281","volume-title":"The role of Toll-like receptor (TLR) polymorphisms in urinary bladder cancer","author":"P Behzadi","year":"2021","unstructured":"Behzadi P (2021b) The role of Toll-like receptor (TLR) polymorphisms in urinary bladder cancer. Springer, In Genetic Polymorphism and cancer susceptibility, pp 281\u2013317"},{"key":"4643_CR11","first-page":"379","volume-title":"Toll-like receptor (TLR) polymorphisms in prostate cancer","author":"P Behzadi","year":"2022","unstructured":"Behzadi P (2022) Toll-like receptor (TLR) polymorphisms in prostate cancer. CRC Press, In Genetic Polymorphism and Disease, pp 379\u2013399"},{"key":"4643_CR12","first-page":"445","volume":"28","author":"P Behzadi","year":"2008","unstructured":"Behzadi P, Behzadi E (2008) The microbial agents of urinary tract infections at central laboratory of Dr. Shariati Hospital, Tehran, Iran. Turk Klin Tip Bilim 28:445\u2013449","journal-title":"Turk Klin Tip Bilim"},{"key":"4643_CR13","first-page":"404","volume":"69","author":"E Behzadi","year":"2016","unstructured":"Behzadi E, Behzadi P (2016) The role of toll-like receptors (TLRs) in urinary tract infections (UTIs). Cent Eur J Urol 69:404","journal-title":"Cent Eur J Urol"},{"key":"4643_CR14","doi-asserted-by":"crossref","unstructured":"Behzadi P, Behzadi E (2017) Uropathogenic Escherichia coli: an ideal resource for DNA microarray probe designing. In Proceedings of the Bioinformatics and Biomedical Engineering: 5th International Work-Conference, IWBBIO 2017, Granada, Spain, April 26\u201328, 2017, Proceedings, Part II 5, pp. 12\u201319.","DOI":"10.1007\/978-3-319-56154-7_2"},{"key":"4643_CR15","doi-asserted-by":"crossref","unstructured":"Behzadi P, Dodero VI, Golubnitschaja O (2024) Systemic inflammation as the health-related communication tool between the human host and gut microbiota in the framework of predictive, preventive, and personalized medicine. In All around suboptimal health: advanced approaches by predictive, preventive and personalised medicine for healthy populations; Springer: pp. 203\u2013241.","DOI":"10.1007\/978-3-031-46891-9_15"},{"key":"4643_CR16","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.17449","author":"P Behzadi","year":"2015","unstructured":"Behzadi P, Ranjbar R, Alavian SM (2015) Nucleic acid-based approaches for detection of viral hepatitis. Jundishapur J Microbiol. https:\/\/doi.org\/10.5812\/jjm.17449","journal-title":"Jundishapur J Microbiol"},{"key":"4643_CR17","first-page":"105","volume":"69","author":"P Behzadi","year":"2016","unstructured":"Behzadi P, Najafi A, Behzadi E, Ranjbar R (2016) Microarray long oligo probe designing for Escherichia coli: an in-silico DNA marker extraction. CEJU 69:105\u2013111","journal-title":"CEJU"},{"key":"4643_CR18","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1007\/s11033-020-05651-9","volume":"47","author":"P Behzadi","year":"2020","unstructured":"Behzadi P, Garc\u00eda-Perdomo HA, Karpi\u0144ski TM, Issakhanian L (2020) Metallo-\u00df-lactamases: a review. Mol Biol Rep 47:6281\u20136294","journal-title":"Mol Biol Rep"},{"key":"4643_CR19","first-page":"35","volume":"15","author":"P Behzadi","year":"2021","unstructured":"Behzadi P, Urb\u00e1n E, Matuz M, Benk\u0151 R, Gajd\u00e1cs M (2021) The role of gram-negative bacteria in urinary tract infections: current concepts and therapeutic options. Advances in Microbiology, Infectious Diseases and Public Health 15:35\u201369","journal-title":"Advances in Microbiology, Infectious Diseases and Public Health"},{"key":"4643_CR20","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3390\/pathogens11091015","volume":"11","author":"P Behzadi","year":"2022","unstructured":"Behzadi P, Gajd\u00e1cs M, Pall\u00f3s P, \u00d3nodi B, St\u00e1jer A, Matusovits D, K\u00e1rp\u00e1ti K, Buri\u00e1n K, Battah B, Ferrari M (2022a) Relationship between biofilm-formation, phenotypic virulence factors and antibiotic resistance in environmental Pseudomonas aeruginosa. Pathogens 11:1015","journal-title":"Pathogens"},{"key":"4643_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.975616","volume":"13","author":"P Behzadi","year":"2022","unstructured":"Behzadi P, Ambrosi C, Scribano D, Zanetti S, Sarshar M, Gajd\u00e1cs M, Donadu MG (2022b) Current perspectives on Pseudomonas aeruginosa: epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens. Front Microbiol 13:975616","journal-title":"Front Microbiol"},{"key":"4643_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1294869","volume":"14","author":"P Behzadi","year":"2023","unstructured":"Behzadi P, Kim C-H, Pawlak EA, Algammal A (2023a) The innate and adaptive immune system in human urinary system. Front Immunol 14:1294869","journal-title":"Front Immunol"},{"key":"4643_CR23","first-page":"1183236","volume":"14","author":"P Behzadi","year":"2023","unstructured":"Behzadi P, Garc\u00eda-Perdomo HA, Autr\u00e1n G\u00f3mez AM, Pinheiro M (2023b) Sarshar, M. Uropathogens, Urinary Tract Infections, the Host-Pathogen Interactions and Treatment 14:1183236","journal-title":"Uropathogens, Urinary Tract Infections, the Host-Pathogen Interactions and Treatment"},{"key":"4643_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.137836","volume":"284","author":"P Behzadi","year":"2025","unstructured":"Behzadi P, Chandran D, Chakraborty C, Bhattacharya M, Saikumar G, Dhama K, Chakraborty A, Mukherjee S, Sarshar M (2025) The dual role of toll-like receptors in COVID-19: balancing protective immunity and immunopathogenesis. Int J Biol Macromol 284:137836","journal-title":"Int J Biol Macromol"},{"key":"4643_CR25","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025239","volume":"7","author":"RA Bonomo","year":"2017","unstructured":"Bonomo RA (2017) \u0392-lactamases: a focus on current challenges. Cold Spring Harb Perspect Med 7:a025239","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4643_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/cid\/ciad288","volume":"77","author":"AE Boutzoukas","year":"2023","unstructured":"Boutzoukas AE, Komarow L, Chen L, Hanson B, Kanj SS, Liu Z, Salcedo Mendoza S, Ordo\u00f1ez K, Wang M, Paterson DL (2023) International epidemiology of carbapenemase-producing Escherichia coli. Clin Infect Dis 77:499\u2013509","journal-title":"Clin Infect Dis"},{"key":"4643_CR27","doi-asserted-by":"publisher","unstructured":"Boyd SE, Livermore DM, Hooper DC, Hope WW (2020) Metallo-\u03b2-lactamases: structure, function, epidemiology, treatment options, and the development pipeline. Antimicrob Agents Chemother 64:00397\u201300320.\u00a0https:\/\/doi.org\/10.1128\/aac.\u00a0","DOI":"10.1128\/aac"},{"key":"4643_CR28","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025247","volume":"6","author":"K Bush","year":"2016","unstructured":"Bush K, Bradford PA (2016) \u03b2-lactams and \u03b2-lactamase inhibitors: an overview. Cold Spring Harb Perspect Med 6:a025247","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4643_CR29","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3390\/microorganisms11061491","volume":"11","author":"O Caliskan-Aydogan","year":"2023","unstructured":"Caliskan-Aydogan O, Alocilja EC (2023) A review of carbapenem resistance in Enterobacterales and its detection techniques. Microorganisms 11:1491","journal-title":"Microorganisms"},{"key":"4643_CR30","doi-asserted-by":"publisher","first-page":"1368622","DOI":"10.3389\/fcimb.2024.1368622","volume":"14","author":"LC Carrera P\u00e1ez","year":"2024","unstructured":"Carrera P\u00e1ez LC, Olivier M, Gambino AS, Poklepovich T, Aguilar AP, Quiroga MP, Centr\u00f3n D (2024) Sporadic clone Escherichia coli ST615 as a vector and reservoir for dissemination of crucial antimicrobial resistance genes. Front Cell Infect Microbiol 14:1368622","journal-title":"Front Cell Infect Microbiol"},{"key":"4643_CR31","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1093\/jac\/dkx131","volume":"72","author":"S Chatterjee","year":"2017","unstructured":"Chatterjee S, Mondal A, Mitra S, Basu S (2017) Acinetobacter baumannii transfers the bla NDM-1 gene via outer membrane vesicles. J Antimicrob Chemother 72:2201\u20132207","journal-title":"J Antimicrob Chemother"},{"key":"4643_CR32","unstructured":"CLSI (2023) Performance standards for antimicrobial susceptibility testing. 33rd ed.; CLSI Supplement M100; Clinical and Laboratory Standards Institute, USA."},{"key":"4643_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/medsci6010001","author":"FS Codjoe","year":"2017","unstructured":"Codjoe FS, Donkor ES (2017) Carbapenem resistance: a review. Med Sci. https:\/\/doi.org\/10.3390\/medsci6010001","journal-title":"Med Sci"},{"key":"4643_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145090","volume":"21","author":"G De Angelis","year":"2020","unstructured":"De Angelis G, Del Giacomo P, Posteraro B, Sanguinetti M, Tumbarello M (2020) Molecular mechanisms, epidemiology, and clinical importance of \u03b2-lactam resistance in Enterobacteriaceae. Int J Mol Sci 21:5090","journal-title":"Int J Mol Sci"},{"key":"4643_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.plasmid.2019.01.003","volume":"102","author":"F Dionisio","year":"2019","unstructured":"Dionisio F, Zilh\u00e3o R, Gama JA (2019) Interactions between plasmids and other mobile genetic elements affect their transmission and persistence. Plasmid 102:29\u201336","journal-title":"Plasmid"},{"key":"4643_CR36","first-page":"1536258","volume":"15","author":"VI Dodero","year":"2024","unstructured":"Dodero VI, Morr\u00e9 SA, Behzadi P (2024) Gut Microbiota and Immunity in Health and Disease: dYsbiosis and Eubiosis\u2019s Effects on the Human Body 15:1536258","journal-title":"Gut Microbiota and Immunity in Health and Disease: dYsbiosis and Eubiosis\u2019s Effects on the Human Body"},{"key":"4643_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1469-0691.2007.01846.x","volume":"14","author":"L Drieux","year":"2008","unstructured":"Drieux L, Brossier F, Sougakoff W, Jarlier V (2008) Phenotypic detection of extended-spectrum \u03b2-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect 14:90\u2013103","journal-title":"Clin Microbiol Infect"},{"key":"4643_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/antibiotics8020037","volume":"8","author":"EM Eichenberger","year":"2019","unstructured":"Eichenberger EM, Thaden JT (2019) Epidemiology and mechanisms of resistance of extensively drug resistant gram-negative bacteria. Antibiotics 8:37","journal-title":"Antibiotics"},{"issue":"3","key":"4643_CR39","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2019-0098","volume":"6","author":"A Elshamy","year":"2020","unstructured":"Elshamy A, Aboshanab K (2020) A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options. Future Sci OA 6(3):FSO438","journal-title":"Future Sci OA"},{"key":"4643_CR40","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3390\/antibiotics13090900","volume":"13","author":"A Estany-Gestal","year":"2024","unstructured":"Estany-Gestal A, Salgado-Barreira A, Vazquez-Lago JM (2024) Antibiotic use and antimicrobial resistance: a global public health crisis. Antibiotics 13:900","journal-title":"Antibiotics"},{"key":"4643_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104588","volume":"86","author":"N Farhat","year":"2020","unstructured":"Farhat N, Khan AU (2020) Evolving trends of New Delhi Metallo-betalactamse (NDM) variants: a threat to antimicrobial resistance. Infect Genet Evol 86:104588","journal-title":"Infect Genet Evol"},{"key":"4643_CR42","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.cmi.2015.12.002","volume":"22","author":"ND Friedman","year":"2016","unstructured":"Friedman ND, Temkin E, Carmeli Y (2016) The negative impact of antibiotic resistance. Clin Microbiol Infect 22:416\u2013422","journal-title":"Clin Microbiol Infect"},{"key":"4643_CR43","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S356960","author":"Z Gao","year":"2022","unstructured":"Gao Z, Liu Y, Zhang L, Yang Z, Lv L, Wang S, Chen L, Zhou N, Zhu Y, Jiang X (2022) Nociceptor neurons are involved in the host response to Escherichia coli urinary tract infections. J Inflamm Res. https:\/\/doi.org\/10.2147\/JIR.S356960","journal-title":"J Inflamm Res"},{"key":"4643_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1574-6968.2007.00695.x","volume":"271","author":"A Garc\u00eda","year":"2007","unstructured":"Garc\u00eda A, Navarro F, Miro E, Villa L, Mirelis B, Coll P, Carattoli A (2007) Acquisition and diffusion of bla CTX-M-9 gene by R478-IncHI2 derivative plasmids. FEMS Microbiol Lett 271:71\u201377","journal-title":"FEMS Microbiol Lett"},{"key":"4643_CR45","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12866-024-03472-5","volume":"24","author":"T Golpasand","year":"2024","unstructured":"Golpasand T, Keshvari M, Behzadi P (2024) Distribution of chaperone-usher fimbriae and curli fimbriae among uropathogenic Escherichia coli. BMC Microbiol 24:344","journal-title":"BMC Microbiol"},{"key":"4643_CR46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1473-3099(16)30257-2","volume":"17","author":"H Grundmann","year":"2017","unstructured":"Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT, Andrasevi\u0107 AT, Cant\u00f3n R, Carmeli Y, Friedrich AW, Giske CG (2017) Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis 17:153\u2013163","journal-title":"Lancet Infect Dis"},{"key":"4643_CR47","doi-asserted-by":"publisher","unstructured":"Haidar G, Clancy CJ, Chen L, Samanta P, Shields RK, Kreiswirth BN, Nguyen MH (2017) Identifying spectra of activity and therapeutic niches for ceftazidime-avibactam and imipenem-relebactam against carbapenem-resistant Enterobacteriaceae. Antimicrobial agents and chemotherapy 61:00642\u201300617.\u00a0https:\/\/doi.org\/10.1128\/aac.\u00a0","DOI":"10.1128\/aac"},{"key":"4643_CR48","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3390\/microorganisms11061407","volume":"11","author":"M Harris","year":"2023","unstructured":"Harris M, Fasolino T, Ivankovic D, Davis NJ, Brownlee N (2023) Genetic factors that contribute to antibiotic resistance through intrinsic and acquired bacterial genes in urinary tract infections. Microorganisms 11:1407","journal-title":"Microorganisms"},{"key":"4643_CR49","doi-asserted-by":"crossref","unstructured":"Hilal S, Maqbool S, Bhat D, Tabassum N\u00a0(n.d.) Probiotics in urinary tract infection: potential strategies to address antimicrobial resistance. In Probiotics against Antimicrobial Resistance; CRC Press: pp. 217\u2013231.","DOI":"10.1201\/9781032676951-13"},{"key":"4643_CR50","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s13353-020-00542-y","volume":"61","author":"A Hozzari","year":"2020","unstructured":"Hozzari A, Behzadi P, Kerishchi Khiabani P, Sholeh M, Sabokroo N (2020) Clinical cases, drug resistance, and virulence genes profiling in Uropathogenic Escherichia coli. J Appl Genet 61:265\u2013273","journal-title":"J Appl Genet"},{"key":"4643_CR51","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.2174\/1381612825999190619130216","volume":"25","author":"L Issakhanian","year":"2019","unstructured":"Issakhanian L, Behzadi P (2019) Antimicrobial agents and urinary tract infections. Curr Pharm Des 25:1409\u20131423","journal-title":"Curr Pharm Des"},{"key":"4643_CR52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/antibiotics13010059","volume":"13","author":"LM Jacobs","year":"2024","unstructured":"Jacobs LM, Consol P, Chen Y (2024) Drug discovery in the field of \u03b2-lactams: an academic perspective. Antibiotics 13:59","journal-title":"Antibiotics"},{"key":"4643_CR53","first-page":"452","volume":"68","author":"N Jahandeh","year":"2015","unstructured":"Jahandeh N, Ranjbar R, Behzadi P, Behzadi E (2015) Uropathogenic Escherichia coli virulence genes: invaluable approaches for designing DNA microarray probes. CEJU 68:452\u2013458","journal-title":"CEJU"},{"key":"4643_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13205-024-04101-8","volume":"14","author":"A Kapoor","year":"2024","unstructured":"Kapoor A, Mudaliar SB, Bhat VG, Chakraborty I, Prasad ASB, Mazumder N (2024) Phage therapy: a novel approach against multidrug-resistant pathogens. 3 Biotech 14:1\u201320","journal-title":"3 Biotech"},{"key":"4643_CR55","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/antibiotics12020234","volume":"12","author":"T Karampatakis","year":"2023","unstructured":"Karampatakis T, Tsergouli K, Behzadi P (2023) Carbapenem-resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics 12:234","journal-title":"Antibiotics"},{"key":"4643_CR56","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3390\/antibiotics13030257","volume":"13","author":"T Karampatakis","year":"2024","unstructured":"Karampatakis T, Tsergouli K, Behzadi P (2024) Pan-genome plasticity and virulence factors: a natural treasure trove for Acinetobacter baumannii. Antibiotics 13:257","journal-title":"Antibiotics"},{"key":"4643_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13091983","volume":"13","author":"T Karampatakis","year":"2025","unstructured":"Karampatakis T, Tsergouli K, Behzadi P (2025a) Carbapenem-resistant Acinetobacter baumannii: virulence factors, molecular epidemiology, and latest updates in treatment options. Microorganisms 13:1983","journal-title":"Microorganisms"},{"key":"4643_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14040353","volume":"14","author":"T Karampatakis","year":"2025","unstructured":"Karampatakis T, Tsergouli K, Behzadi P (2025b) Carbapenem-resistant Pseudomonas aeruginosa\u2019s resistome: pan-genomic plasticity, the impact of transposable elements and jumping genes. Antibiotics 14:353","journal-title":"Antibiotics"},{"key":"4643_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.mgene.2021.100881","volume":"28","author":"MS Khonsari","year":"2021","unstructured":"Khonsari MS, Behzadi P, Foroohi F (2021) The prevalence of type 3 fimbriae in uropathogenic Escherichia coli isolated from clinical urine samples. Meta Gene 28:100881","journal-title":"Meta Gene"},{"key":"4643_CR60","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","volume":"8","author":"DM Lin","year":"2017","unstructured":"Lin DM, Koskella B, Lin HC (2017) Phage therapy: an alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther 8:162","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"4643_CR61","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1128\/JCM.02771-15","volume":"54","author":"JD Lutgring","year":"2016","unstructured":"Lutgring JD, Limbago BM (2016) The problem of carbapenemase-producing-carbapenem-resistant-Enterobacteriaceae detection. J Clin Microbiol 54:529\u2013534","journal-title":"J Clin Microbiol"},{"key":"4643_CR62","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"A-P Magiorakos","year":"2012","unstructured":"Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas M, Giske C, Harbarth S, Hindler J, Kahlmeter G, Olsson-Liljequist B (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268\u2013281","journal-title":"Clin Microbiol Infect"},{"key":"4643_CR63","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12223-019-00750-y","volume":"65","author":"S Malik","year":"2020","unstructured":"Malik S, Sidhu PK, Rana J, Nehra K (2020) Managing urinary tract infections through phage therapy: a novel approach. Folia Microbiol 65:217\u2013231","journal-title":"Folia Microbiol"},{"key":"4643_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00039","volume":"7","author":"MF Moradali","year":"2017","unstructured":"Moradali MF, Ghods S, Rehm BH (2017) Pseudomonas aeruginosa lifestyle: a paradigm for adaptation, survival, and persistence. Front Cell Infect Microbiol 7:39","journal-title":"Front Cell Infect Microbiol"},{"key":"4643_CR65","doi-asserted-by":"publisher","first-page":"1244345","DOI":"10.3389\/fimmu.2023.1244345","volume":"14","author":"S Mukherjee","year":"2023","unstructured":"Mukherjee S, Patra R, Behzadi P, Masotti A, Paolini A, Sarshar M (2023) Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives. Front Immunol 14:1244345","journal-title":"Front Immunol"},{"key":"4643_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0001344","volume":"3","author":"J Muleme","year":"2023","unstructured":"Muleme J, Musoke D, Balugaba BE, Kisaka S, Makumbi FE, Buregyeya E, Isunju JB, Wambi R, Mugambe RK, Kankya C (2023) Epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli at the human-animal-environment interface in a farming community of central Uganda. PLoS Glob Public Health 3:e0001344","journal-title":"PLoS Glob Public Health"},{"key":"4643_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07502-0","author":"KA Mu\u00f1oz","year":"2024","unstructured":"Mu\u00f1oz KA, Ulrich RJ, Vasan AK, Sinclair M, Wen P-C, Holmes JR, Lee HY, Hung C-C, Fields CJ, Tajkhorshid E (2024) A gram-negative-selective antibiotic that spares the gut microbiome. Nature. https:\/\/doi.org\/10.1038\/s41586-024-07502-0","journal-title":"Nature"},{"key":"4643_CR68","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/14756366.2017.1344235","volume":"32","author":"T Naas","year":"2017","unstructured":"Naas T, Oueslati S, Bonnin RA, Dabos ML, Zavala A, Dortet L, Retailleau P, Iorga BI (2017) Beta-lactamase database (BLDB)\u2013structure and function. J Enzyme Inhib Med Chem 32:917\u2013919","journal-title":"J Enzyme Inhib Med Chem"},{"key":"4643_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13020194","volume":"13","author":"M Nasser-Ali","year":"2024","unstructured":"Nasser-Ali M, Aja-Macaya P, Conde-P\u00e9rez K, Trigo-Tasende N, Rumbo-Feal S, Fern\u00e1ndez-Gonz\u00e1lez A, Bou G, Poza M, Vallejo JA (2024) Emergence of carbapenemase genes in gram-negative bacteria isolated from the wastewater treatment plant in A Coru\u00f1a. Spain. Antibiotics 13:194","journal-title":"Antibiotics"},{"key":"4643_CR70","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11934-022-01085-x","volume":"23","author":"FJ New","year":"2022","unstructured":"New FJ, Theivendrampillai S, Julieb\u00f8-Jones P, Somani B (2022) Role of probiotics for recurrent UTIs in the twenty-first century: a systematic review of literature. Curr Urol Rep 23:19\u201328","journal-title":"Curr Urol Rep"},{"key":"4643_CR71","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00705-007-0031-4","volume":"153","author":"H Nishikawa","year":"2008","unstructured":"Nishikawa H, Yasuda M, Uchiyama J, Rashel M, Maeda Y, Takemura I, Sugihara S, Ujihara T, Shimizu Y, Shuin T (2008) T-even-related bacteriophages as candidates for treatment of Escherichia coli urinary tract infections. Arch Virol 153:507\u2013515","journal-title":"Arch Virol"},{"key":"4643_CR72","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.3390\/molecules29163944","volume":"29","author":"JL Ortega-Balleza","year":"2024","unstructured":"Ortega-Balleza JL, V\u00e1zquez-Jim\u00e9nez LK, Ortiz-P\u00e9rez E, Avalos-Navarro G, Paz-Gonz\u00e1lez AD, Lara-Ram\u00edrez EE, Rivera G (2024) Current strategy for targeting metallo-\u03b2-lactamase with metal-ion-binding inhibitors. Molecules 29:3944","journal-title":"Molecules"},{"key":"4643_CR73","doi-asserted-by":"publisher","first-page":"1394953","DOI":"10.3389\/fnins.2024.1394953","volume":"18","author":"P Petakh","year":"2024","unstructured":"Petakh P, Duve K, Oksenych V, Behzadi P, Kamyshnyi O (2024) Molecular mechanisms and therapeutic possibilities of short-chain fatty acids in posttraumatic stress disorder patients: a mini-review. Front Neurosci 18:1394953","journal-title":"Front Neurosci"},{"key":"4643_CR74","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1128\/AAC.01019-15","volume":"59","author":"JD Pitout","year":"2015","unstructured":"Pitout JD, Nordmann P, Poirel L (2015) Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 59:5873\u20135884","journal-title":"Antimicrob Agents Chemother"},{"key":"4643_CR75","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","volume":"70","author":"L Poirel","year":"2011","unstructured":"Poirel L, Walsh TR, Cuvillier V, Nordmann P (2011) Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70:119\u2013123","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4643_CR76","doi-asserted-by":"publisher","first-page":"C134","DOI":"10.1152\/ajpcell.00054.2021","volume":"321","author":"H Praetorius","year":"2021","unstructured":"Praetorius H (2021) The bacteria and the host: a story of purinergic signaling in urinary tract infections. Am J Physiol Cell Physiol 321:C134\u2013C146","journal-title":"Am J Physiol Cell Physiol"},{"key":"4643_CR77","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1128\/CMR.00001-07","volume":"20","author":"AM Queenan","year":"2007","unstructured":"Queenan AM, Bush K (2007) Carbapenemases: the versatile \u03b2-lactamases. Clin Microbiol Rev 20:440\u2013458","journal-title":"Clin Microbiol Rev"},{"key":"4643_CR78","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2174\/1874285801610010176","volume":"10","author":"R Ranjbar","year":"2016","unstructured":"Ranjbar R, Behzadi P, Mammina C (2016) Respiratory tularemia: Francisella tularensis and microarray probe designing. Open Microbiol J 10:176","journal-title":"Open Microbiol J"},{"key":"4643_CR79","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2174\/1874285801711010330","volume":"11","author":"R Ranjbar","year":"2017","unstructured":"Ranjbar R, Behzadi P, Najafi A, Roudi R (2017) DNA microarray for rapid detection and identification of food and water borne bacteria: from dry to wet lab. Open Microbiol J 11:330","journal-title":"Open Microbiol J"},{"key":"4643_CR80","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3390\/antibiotics12101481","volume":"12","author":"L Razaq","year":"2023","unstructured":"Razaq L, Uddin F, Ali S, Abbasi SM, Sohail M, Yousif NE, Abo-Dief HM, El-Bahy ZM (2023) In vitro activity of new \u03b2-lactamase inhibitor combinations against bla NDM, bla KPC, and ESBL-producing Enterobacteriales uropathogens. Antibiotics 12:1481","journal-title":"Antibiotics"},{"key":"4643_CR81","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1093\/jac\/dkad150","volume":"78","author":"E Riccobono","year":"2023","unstructured":"Riccobono E, Salvetti S, Coppi M, Montenora I, Di Pilato V, Rossolini GM (2023) Citrobacter freundii resistant to novel \u03b2-lactamase inhibitor combinations and cefiderocol, co-producing class A, B and D carbapenemases encoded by transferable plasmids. J Antimicrob Chemother 78:1677\u20131682","journal-title":"J Antimicrob Chemother"},{"key":"4643_CR82","doi-asserted-by":"publisher","unstructured":"Samanta, P.D., R.J. Applying molecular modeling to predict novel FmlH-binding glycomimetics with improved pharmacokinetic properties for the prevention of urinary tract infections Appl. Sci. 2024, 14, https:\/\/doi.org\/10.3390\/app14209496.","DOI":"10.3390\/app14209496"},{"key":"4643_CR83","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/antibiotics9070397","volume":"9","author":"M Sarshar","year":"2020","unstructured":"Sarshar M, Behzadi P, Ambrosi C, Zagaglia C, Palamara AT, Scribano D (2020) FimH and anti-adhesive therapeutics: a disarming strategy against uropathogens. Antibiotics 9:397","journal-title":"Antibiotics"},{"key":"4643_CR84","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0147-619X(02)00107-5","volume":"49","author":"M Sherley","year":"2003","unstructured":"Sherley M, Gordon DM, Collignon PJ (2003) Species differences in plasmid carriage in the Enterobacteriaceae. Plasmid 49:79\u201385","journal-title":"Plasmid"},{"key":"4643_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10050476","volume":"10","author":"V Silago","year":"2021","unstructured":"Silago V, Kovacs D, Samson H, Seni J, Matthews L, Oravcov\u00e1 K, Lupindu AM, Hoza AS, Mshana SE (2021) Existence of multiple ESBL genes among phenotypically confirmed ESBL producing Klebsiella pneumoniae and Escherichia coli concurrently isolated from clinical, colonization and contamination samples from neonatal units at Bugando Medical Center, Mwanza, Tanzania. Antibiotics 10:476","journal-title":"Antibiotics"},{"key":"4643_CR86","unstructured":"Suay-Garc\u00eda B, P\u00e9rez-Gracia MT (2021) Present and future of carbapenem-resistant Enterobacteriaceae infections. Advances in clinical immunology, medical microbiology, COVID-19, and big data 435\u2013456."},{"key":"4643_CR87","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1128\/AAC.45.3.649-659.2001","volume":"45","author":"A Sulakvelidze","year":"2001","unstructured":"Sulakvelidze A, Alavidze Z, Morris JG Jr (2001) Bacteriophage therapy. Antimicrob Agents Chemother 45:649\u2013659","journal-title":"Antimicrob Agents Chemother"},{"key":"4643_CR88","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S337611","author":"M Tilahun","year":"2021","unstructured":"Tilahun M, Kassa Y, Gedefie A, Ashagire M (2021) Emerging carbapenem-resistant Enterobacteriaceae infection, its epidemiology and novel treatment options: a review. Infect Drug Resist. https:\/\/doi.org\/10.2147\/IDR.S337611","journal-title":"Infect Drug Resist"},{"key":"4643_CR89","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1016\/j.jmb.2019.04.002","volume":"431","author":"CL Tooke","year":"2019","unstructured":"Tooke CL, Hinchliffe P, Bragginton EC, Colenso CK, Hirvonen VH, Takebayashi Y, Spencer J (2019) \u03b2-lactamases and \u03b2-lactamase inhibitors in the 21st century. J Mol Biol 431:3472\u20133500","journal-title":"J Mol Biol"},{"key":"4643_CR90","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1128\/JCM.38.2.542-546.2000","volume":"38","author":"E Tzelepi","year":"2000","unstructured":"Tzelepi E, Giakkoupi P, Sofianou D, Loukova V, Kemeroglou A, Tsakris A (2000) Detection of extended-spectrum \u03b2-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol 38:542\u2013546","journal-title":"J Clin Microbiol"},{"key":"4643_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01832","volume":"9","author":"A Ujmajuridze","year":"2018","unstructured":"Ujmajuridze A, Chanishvili N, Goderdzishvili M, Leitner L, Mehnert U, Chkhotua A, Kessler TM, Sybesma W (2018) Adapted bacteriophages for treating urinary tract infections. Front Microbiol 9:1832","journal-title":"Front Microbiol"},{"key":"4643_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/fermentation10120599","author":"P Vinayamohan","year":"2024","unstructured":"Vinayamohan P, Joseph D, Viju LS, Baskaran SA, Venkitanarayanan K (2024) Efficacy of probiotics in reducing pathogenic potential of infectious agents. Fermentation. https:\/\/doi.org\/10.3390\/fermentation10120599","journal-title":"Fermentation"},{"key":"4643_CR93","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","volume":"403","author":"SE Vollset","year":"2024","unstructured":"Vollset SE, Ababneh HS, Abate YH, Abbafati C, Abbasgholizadeh R, Abbasian M, Abbastabar H, Abd Al Magied AH, Abd ElHafeez S, Abdelkader A (2024) Burden of disease scenarios for 204 countries and territories, 2022\u20132050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet 403:2204\u20132256","journal-title":"Lancet"},{"key":"4643_CR94","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jprot.2018.05.017","volume":"187","author":"T Wagner","year":"2018","unstructured":"Wagner T, Joshi B, Janice J, Askarian F, \u0160kalko-Basnet N, Hagestad OC, Mekhlif A, Wai SN, Hegstad K, Johannessen M (2018) Enterococcus faecium produces membrane vesicles containing virulence factors and antimicrobial resistance related proteins. J Proteomics 187:28\u201338","journal-title":"J Proteomics"},{"key":"4643_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.614058","volume":"12","author":"E-J Yoon","year":"2021","unstructured":"Yoon E-J, Jeong SH (2021) Mobile carbapenemase genes in Pseudomonas aeruginosa. Front Microbiol 12:614058","journal-title":"Front Microbiol"},{"key":"4643_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2023.215326","volume":"493","author":"M Zabiszak","year":"2023","unstructured":"Zabiszak M, Frymark J, Ogawa K, Skroba\u0144ska M, Nowak M, Jastrzab R, Kaczmarek MT (2023) Complexes of \u03b2-lactam antibiotics and their Schiff-base derivatives as a weapon in the fight against bacterial resistance. Coord Chem Rev 493:215326","journal-title":"Coord Chem Rev"},{"key":"4643_CR97","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/14787210.2024.2311213","volume":"22","author":"J Zakhour","year":"2024","unstructured":"Zakhour J, El Ayoubi LEW, Kanj SS (2024) Metallo-beta-lactamases: mechanisms, treatment challenges, and future prospects. Expert Rev Anti-Infect Ther 22:189\u2013201","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"4643_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9060304","volume":"9","author":"B Zalewska-Pi\u0105tek","year":"2020","unstructured":"Zalewska-Pi\u0105tek B, Pi\u0105tek R (2020) Phage therapy as a novel strategy in the treatment of urinary tract infections caused by E. coli. Antibiotics 9:304","journal-title":"Antibiotics"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04643-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04643-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04643-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:03:03Z","timestamp":1772780583000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04643-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":98,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4643"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04643-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This paper is extracted from MSc thesis (MSc student: Shervindokht Ahmadi) approved by the Islamic Azad University, Shahr-e-Qods Branch. Moreover, the ethical approval was achieved under Ethical number of\n                      \n                        IR.IAU.QODS.REC.1402.005\n                      \n                      by the Ethics Committee of the Islamic Azad University, Shahr-e-Qods Branch. As the patients\u2019 information was anonymized, no informed consent was required. The age and gender of the patients with UTIs were available to us, but their clinical signs and symptoms were not. The research was conducted in accordance with the Declaration of Helsinki guidelines. Due to the retrospective nature of the study, the Ethics Committee of the Islamic Azad University, Shahr-e-Qods Branch waived the need of obtaining informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no conflict of interest. P.B. is the BMC Infectious Diseases, BMC Microbiology, BMC Research Notes, and Archives of Microbiology editorial board member.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"AI tools were employed to polish the language and correct spelling and grammatical errors in the manuscript.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI use statement"}}]}}